| tenofovir disoproxil fumarate / Generic mfg. |
NCT01728935: Tenofovir in Asian Chronic Hepatitis B Patients |
|
|
| Completed | N/A | 141 | RoW | Tenofovir disoproxil, Viread | The University of Hong Kong, Gilead Sciences | Chronic Hepatitis B | 11/12 | 03/13 | | |
NCT01267162: Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients |
|
|
| Completed | N/A | 31 | US | | Medical Procare PLLC | Chronic Hepatitis B | 11/13 | 11/13 | | |
NCT01715987: Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment |
|
|
| Terminated | N/A | 48 | US | Tenofovir Disoproxil Fumarate, Viread, Entecavir, Baraclude | New Discovery LLC | Hepatitis B | 05/16 | 05/16 | | |
NCT01918631: A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir |
|
|
| Completed | N/A | 36 | RoW | tenofovir disoproxil fumarate, Entecavir | Chinese University of Hong Kong | Chronic Heptitis B | 01/17 | 01/17 | | |
NCT02258581 / 2015-001050-16: Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection |
|
|
| Terminated | N/A | 241 | US, Canada, Europe, RoW | GS-4774, GS-9620, Tenofovir disoproxil fumarate (TDF), Viread® | Gilead Sciences | Chronic Hepatitis B | 08/17 | 08/17 | | |
NCT02533544: Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B |
|
|
| Completed | N/A | 572 | RoW | tenofovir disoproxil fumarate | Myeong Jun Song, Gilead Sciences, Wonkwang University, Soonchunhyang University Hospital, Chungnam National University Hospital, Konyang University Hospital | Chronic Hepatitis B | 10/18 | 10/18 | | |
